However, only one study reported the BNP level in CTEPH patients with riociguat therapy (standard mean difference = −0.3 pg/mL, 95% CI: [−0.83, −0.33]). This evidence concerns the gene NPPB and chronic thromboembolic pulmonary hypertension.